Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Seminars in Nuclear Medicine
|
March 17, 2020
Radium-223 as an Approved Modality for Treatment of Bone Metastases
Ana Emília Brito, Elba Etchebehere
Seminars in Nuclear Medicine
|
December 18, 2025
Assessing therapeutic response to Radium-223
Caroline Torricelli, Ludmila Almeida, Elba Etchebehere
Seminars in Nuclear Medicine
|
October 11, 2024
<sup>18</sup>F-Fluoride PET/CT-Updates
Ellen Nogueira-Lima, Thiago Alves, Elba Etchebehere
Current Radiopharmaceuticals
|
November 3, 2016
Gallium-68 in Medical Imaging
Lucia Martiniova, Louis De Palatis, Elba Etchebehere, et al.
Clinical Nuclear Medicine
|
July 14, 2020
Typical Acute Traumatic Fracture Healing in an 83-Year-Old Man Undergoing 223Ra Treatment for Prostatic Cancer Bone Metastases
Thaís Minekawa, Mariana Lima, André Moraes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 2, 2017
Therapy assessment of bone metastatic disease in the era of <sup>223</sup>radium
Elba Etchebehere, Ana Emilia Brito, Alireza Rezaee, et al.
Journal of Nuclear Medicine Technology
|
August 5, 2018
Validation of the Semiautomatic Quantification of <sup>18</sup>F-Fluoride PET/CT Whole-Body Skeletal Tumor Burden
Ana E Brito, Felipe Mourato, Allan Santos, et al.
Radiologia Brasileira
|
February 27, 2019
Is interim <sup>18</sup>F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?
Elba Etchebehere, Ana Emília Brito, Kalevi Kairemo, et al.
Current Radiopharmaceuticals
|
June 30, 2018
Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience
Kalevi Kairemo, Denai R Milton, Elba Etchebehere, et al.
Clinical Nuclear Medicine
|
June 9, 2016
Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer
Marcelo A Queiroz, Publio Viana, Allan Santos, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Seminars in Nuclear Medicine
|
March 17, 2020
Radium-223 as an Approved Modality for Treatment of Bone Metastases
Ana Emília Brito, Elba Etchebehere
Seminars in Nuclear Medicine
|
December 18, 2025
Assessing therapeutic response to Radium-223
Caroline Torricelli, Ludmila Almeida, Elba Etchebehere
Seminars in Nuclear Medicine
|
October 11, 2024
<sup>18</sup>F-Fluoride PET/CT-Updates
Ellen Nogueira-Lima, Thiago Alves, Elba Etchebehere
Current Radiopharmaceuticals
|
November 3, 2016
Gallium-68 in Medical Imaging
Lucia Martiniova, Louis De Palatis, Elba Etchebehere, et al.
Clinical Nuclear Medicine
|
July 14, 2020
Typical Acute Traumatic Fracture Healing in an 83-Year-Old Man Undergoing 223Ra Treatment for Prostatic Cancer Bone Metastases
Thaís Minekawa, Mariana Lima, André Moraes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 2, 2017
Therapy assessment of bone metastatic disease in the era of <sup>223</sup>radium
Elba Etchebehere, Ana Emilia Brito, Alireza Rezaee, et al.
Journal of Nuclear Medicine Technology
|
August 5, 2018
Validation of the Semiautomatic Quantification of <sup>18</sup>F-Fluoride PET/CT Whole-Body Skeletal Tumor Burden
Ana E Brito, Felipe Mourato, Allan Santos, et al.
Radiologia Brasileira
|
February 27, 2019
Is interim <sup>18</sup>F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?
Elba Etchebehere, Ana Emília Brito, Kalevi Kairemo, et al.
Current Radiopharmaceuticals
|
June 30, 2018
Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience
Kalevi Kairemo, Denai R Milton, Elba Etchebehere, et al.
Clinical Nuclear Medicine
|
June 9, 2016
Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer
Marcelo A Queiroz, Publio Viana, Allan Santos, et al.
Page
of 4